Resources Contact Us Home
Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety

Image Number 13 for United States Patent #8119616.

The present invention relates to a composition comprising an inclusion complex of a cyclodextrin and quinazoline containing zinc-binding moiety based derivatives. The cyclodextrin is preferable a .beta.-cyclodextrin or a derivative thereof. The quinazolines have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.

  Recently Added Patents
Data encoding and decoding apparatus and method thereof for verifying data integrity
Formation of a masking layer on a dielectric region to facilitate formation of a capping layer on electrically conductive regions separated by the dielectric region
Protecting information written to recording medium
Communication apparatus, and method and program for controlling same
Golf club cover
Liquid crystal display device
Methods and systems for use in tracking targets for direction finding systems
  Randomly Featured Patents
Method and apparatus for simulating standard test wafers
Highly scalable network environment for managing remote devices
Liquid crystal display device
Dual path memory retrieval system for an interleaved dynamic RAM memory unit
Control system for a vehicle/implement hitch
Universal variable length code (UVLC) encoder
Latent mercaptans as multi-functional additives for halogen-containing polymer compositions
Salt water aquarium integrated filter
Novel triazafluoranthene compound and processes for preparing the same
Content addressable memory (CAM) devices that support background BIST and BISR operations and methods of operating same